Literature DB >> 8181460

UDPgalactose:glycoprotein-N-acetyl-D-galactosamine 3-beta-D-galactosyltransferase activity synthesizing O-glycan core 1 is controlled by the amino acid sequence and glycosylation of glycopeptide substrates.

M Granovsky1, T Bielfeldt, S Peters, H Paulsen, M Meldal, J Brockhausen, I Brockhausen.   

Abstract

In order to investigate the role of the peptide moiety of glycoproteins in the control of O-glycan biosynthesis, UDPgalactose:glycoprotein-N-acetyl-D-galactosamine 3-beta-D-galactosyltransferase (core 1 beta 3-Gal-T) from rat liver was tested for its specificity towards GalNAc-containing glycopeptide substrates. Series of glycopeptides have been synthesized by solid-phase synthesis, protected with an acetyl group on the amino terminal and an amide group on the carboxy terminal, based on variations of the repeat sequences of human intestinal mucin. Most glycopeptides were excellent substrates for core 1 beta 3-Gal-T compared to benzyl alpha-D-galactosamine as indicated by their relatively high Vmax/Km. The enzyme preferred threonine alpha-D-galactosamine Thr(GalNAc) to serine alpha-D-galactosamine. Pro on the carboxy-terminal side adjacent to Thr(GalNAc) was inhibitory. Negatively charged amino acids on either side showed a low Km; substrates with negatively charged amino acids on the amino-terminal side were highly efficient substrates, suggesting charge-charge interactions between enzyme and substrate. Gal beta 1-3GalNAc alpha residues adjacent to Thr(GalNAc) reduced the activity. Product analysis using glycopeptide substrates with three adjacent GalNAc residues showed incorporation of one, two and a small amount of three Gal residues per molecule with an uneven distribution of the potential di-galactosylated isomers. These studies indicate that, in addition to initial glycosylation, the second step in the glycosylation pathways of O-glycans is also controlled by the structure and glycosylation of the peptide core of substrates.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8181460     DOI: 10.1111/j.1432-1033.1994.tb18822.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  11 in total

1.  Alternative splicing of repetitive units is responsible for the polydispersities of integumentary mucin B.1 (FIM-B.1) from Xenopus laevis.

Authors:  W Joba; W Hoffmann
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

Review 2.  Human airway mucin glycosylation: a combinatory of carbohydrate determinants which vary in cystic fibrosis.

Authors:  G Lamblin; S Degroote; J M Perini; P Delmotte; A Scharfman; M Davril; J M Lo-Guidice; N Houdret; V Dumur; A Klein; P Rousse
Journal:  Glycoconj J       Date:  2001-09       Impact factor: 2.916

3.  UDP-Gal: GlcNAc-R beta1,4-galactosyltransferase--a target enzyme for drug design. Acceptor specificity and inhibition of the enzyme.

Authors:  Inka Brockhausen; Melinda Benn; Shridhar Bhat; Sandra Marone; John G Riley; Pedro Montoya-Peleaz; Jason Z Vlahakis; Hans Paulsen; John S Schutzbach; Walter A Szarek
Journal:  Glycoconj J       Date:  2006-11       Impact factor: 2.916

4.  Specificity of O-glycosylation by bovine colostrum UDP-GalNAc: polypeptide alpha-N-acetylgalactosaminyltransferase using synthetic glycopeptide substrates.

Authors:  I Brockhausen; D Toki; J Brockhausen; S Peters; T Bielfeldt; A Kleen; H Paulsen; M Meldal; F Hagen; L A Tabak
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

5.  A novel fluorescent assay for T-synthase activity.

Authors:  Tongzhong Ju; Baoyun Xia; Rajindra P Aryal; Wenyi Wang; Yingchun Wang; Xiaokun Ding; Rongjuan Mi; Miao He; Richard D Cummings
Journal:  Glycobiology       Date:  2010-10-19       Impact factor: 4.313

6.  Systematic determination of the peptide acceptor preferences for the human UDP-Gal:glycoprotein-alpha-GalNAc beta 3 galactosyltransferase (T-synthase).

Authors:  Cynthia Perrine; Tongzhong Ju; Richard D Cummings; Thomas A Gerken
Journal:  Glycobiology       Date:  2008-12-10       Impact factor: 4.313

7.  Glycosylation of the two O-glycosylated domains of human MUC2 mucin in patients transposed with artificial urinary bladders constructed from proximal colonic tissue.

Authors:  Catherine Robbe-Masselot; Annkatrin Herrmann; Ingemar Carlstedt; Jean-Claude Michalski; Calliope Capon
Journal:  Glycoconj J       Date:  2007-11-15       Impact factor: 2.916

Review 8.  From imino sugars to cancer glycoproteins.

Authors:  H Paulsen; I Brockhausen
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

9.  Sequence-Specific Mucins for Glycocalyx Engineering.

Authors:  Hao Pan; Marshall J Colville; Nitin T Supekar; Parastoo Azadi; Matthew J Paszek
Journal:  ACS Synth Biol       Date:  2019-10-02       Impact factor: 5.110

10.  Acceptor specificities and selective inhibition of recombinant human Gal- and GlcNAc-transferases that synthesize core structures 1, 2, 3 and 4 of O-glycans.

Authors:  Yin Gao; Rajindra P Aryal; Tongzhong Ju; Richard D Cummings; Gagandeep Gahlay; Donald L Jarvis; Khushi L Matta; Jason Z Vlahakis; Walter A Szarek; Inka Brockhausen
Journal:  Biochim Biophys Acta       Date:  2013-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.